Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H27N3O2.2ClH.H2O |
Molecular Weight | 420.374 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.O=C(N1CCN(CC1)C2CC2)C3=CC=C(CN4CCOCC4)C=C3
InChI
InChIKey=BLFBQJUVAGIUBL-UHFFFAOYSA-N
InChI=1S/C19H27N3O2.2ClH.H2O/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20;;;/h1-4,18H,5-15H2;2*1H;1H2
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C19H27N3O2 |
Molecular Weight | 329.4366 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Bavisant (also known as JNJ-31001074 or BEN-2001), a highly selective, active antagonist of the human H3 receptor that was invented by Johnson & Johnson for the treatment of attention-deficit hyperactivity disorder (ADHD). However, the result of clinical trials did not display significant clinical effectiveness in the treatment of adults with ADHD. BenevolentAI has started phase II clinical trials where investigated bavisant for ameliorating the excessive daytime sleepiness in patients with Parkinson’s disease, using one of the drug side effects is dose-dependent insomnia.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22519922
Participants were randomly assigned equally to one of six treatment groups: placebo, bavisant 1 mg/day, 3 mg/day or 10 mg/day, atomoxetine hydrochloride 80 mg/day or osmotic-release oral system (OROS) methylphenidate hydrochloride 54 mg/day.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:30:40 GMT 2025
by
admin
on
Mon Mar 31 18:30:40 GMT 2025
|
Record UNII |
C1H7H5X3RE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1103522-80-0
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY | |||
|
C1H7H5X3RE
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY | |||
|
300000042590
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL2103862
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY | |||
|
56843503
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY | |||
|
C142947
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY | |||
|
XX-117
Created by
admin on Mon Mar 31 18:30:40 GMT 2025 , Edited by admin on Mon Mar 31 18:30:40 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |